Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 4:522-525 (2007)
© 2007 The American Thoracic Society
doi: 10.1513/pats.200701-004FM

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agustí, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agustí, A.

Systemic Effects of Chronic Obstructive Pulmonary Disease

What We Know and What We Don't Know (but Should)

Alvar Agustí1

1 Servei de Pneumologia, Hospital Universitari Son Dureta, Fundacio Caubet-Cimera Illes Balears, Mallorca, Spain

Correspondence and requests for reprints should be addressed to Dr. Alvar Agustí, Servei Pneumología. Hospital Universitari Son Dureta, Andrea Doria 55, 07014 Palma Mallorca, Spain. E-mail: aagusti{at}hsd.es

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is associated with pulmonary and systemic inflammation. The latter is likely to contribute significantly to the pathobiology of numerous extrapulmonary effects of the disease—the so-called systemic effects of COPD. The clinical relevance of these systemic effects has been recently recognized; however, many important questions about its pathophysiology remain unanswered. This article reviews what is known about it and, more importantly, highlights what is not (but should be) known in order to stimulate research in this area, in the hope that a better understanding of this field may lead to better treatment options for patients with COPD.

Key Words: chronic bronchitis • chronic obstructive pulmonary disease • emphysema • inflammation




This article has been cited by other articles:


Home page
ChestHome page
H. Watz, B. Waschki, A. Kirsten, K.-C. Muller, G. Kretschmar, T. Meyer, O. Holz, and H. Magnussen
The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD: Frequency and Associated Consequences for Systemic Inflammation and Physical Inactivity
Chest, October 1, 2009; 136(4): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S Guerra, D L Sherrill, C Venker, C M Ceccato, M Halonen, and F D Martinez
Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk
Thorax, October 1, 2009; 64(10): 894 - 900.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Chaouat, L. Savale, C. Chouaid, L. Tu, B. Sztrymf, M. Canuet, B. Maitre, B. Housset, C. Brandt, P. Le Corvoisier, et al.
Role for Interleukin-6 in COPD-Related Pulmonary Hypertension
Chest, September 1, 2009; 136(3): 678 - 687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. M.T.A. van Durme, K. M.C. Verhamme, A.-J. L.H.J. Aarnoudse, G. R. Van Pottelberge, A. Hofman, J. C.M. Witteman, G. F. Joos, G. G. Brusselle, and B. H.C. Stricker
C-Reactive Protein Levels, Haplotypes, and the Risk of Incident Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 375 - 382.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. I. Rennard and J. Vestbo
Natural Histories of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 15, 2008; 5(9): 878 - 883.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. B. Soriano and A. Agusti
The of COPD: or balancing repair (yang) and inflammation (yin)
Eur. Respir. J., December 1, 2008; 32(6): 1426 - 1427.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
W. MacNee, J. Maclay, and D. McAllister
Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2008; 5(8): 824 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takeda, P. He, I. Tachibana, B. Zhou, K. Miyado, H. Kaneko, M. Suzuki, S. Minami, T. Iwasaki, S. Goya, et al.
Double Deficiency of Tetraspanins CD9 and CD81 Alters Cell Motility and Protease Production of Macrophages and Causes Chronic Obstructive Pulmonary Disease-like Phenotype in Mice
J. Biol. Chem., September 19, 2008; 283(38): 26089 - 26097.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Agusti
Physical Activity and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 675 - 676.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Thoracic Society.
 
ATS Quiz on Sleep Study Tracings